Last updated: 2026-11-13 15:35:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Opko Health Inc. (OPK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.69, with a market capitalization of $1.24B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.98 to $1.86. This page covers its latest market performance, valuation, price trends and company information.
$1.24B | |
$1.67 | |
$1.72 | |
$1.62 | |
$1.67 | |
330.56K | |
3.78M | |
-- | |
$1.86 | |
$0.98 | |
-- | |
-- |
Opko Health Inc. (OPK) is currently trading at $1.69 as of 2026-11-13 15:18:11, up 0.90% ($0.02) from the previous close of $1.67
During today's regular trading session, OPK has traded between $1.62 and $1.72, with a trading volume of 330.56K shares. The current price is near the middle of today's range.
Over the past seven days, Opko Health Inc. (OPK) moved from $1.75 to $1.69, representing a decline of 3.71% ($0.06).
The stock traded between $1.62 and $1.86 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 3.92 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 80.2%
OPK is currently trading at $1.69, placing it 80.2% of the way from its 52-week low of $0.98 to its 52-week high of $1.86. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2,275 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Opko Health Inc. and OPK stock.
Hims & Hers (HIMS) reported Q3 2026 EPS of 3 cents, missing estimates by 57.1%, though revenues grew 48.7% year-over-year to $890.4 million. The company faced margin compression due to lower-margin weight loss products and a sequential subscriber decline of 100,000. HIMS lowered its full-year adjusted EBITDA guidance to $257-$277 million but raised international revenue outlook to at least $650 million.
Rigetti Computing (RGTI) reported Q2 2026 adjusted loss per share of 6 cents with revenues declining 27.5% to $1.41 million, missing consensus estimates by 57.6%. Despite gross margin expansion to 60.7%, operating losses widened to $33.19 million due to increased R&D spending. The company targets $20 million in 2026 revenues and plans to develop a 300+ qubit quantum system by mid-2028.
Eligible investors can buy real shares of Opko Health Inc. (OPK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Browse other US stocks in the same sector as Opko Health Inc.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to OPK, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between OPK shares and USD.
OPK Shares to USD
1.00 OPK shares = 1.685 USD
Calculations are estimates based on the latest available price and are for reference only.
